Netherlands· NL-7c6397d20f0c
Donepezil HCl Devatis 10 mg, filmomhulde tabletten
A donepezil product containing donepezil + donepezilhydrochloride 1-water, registered in Netherlands by Devatis GmbH. The same ATC class is registered in 18 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Donepezil is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DA02 (donepezil), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Donepezil · ATC N06DA02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of donepezil costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.67 in Italy to $2.77 in Switzerland — a ×4.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Donepezil · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.77
- ES Spain$1.79
- IT Italy$0.67
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DONEPEZIL + DONEPEZILHYDROCHLORIDE 1-WATER
- Manufacturer
- Devatis GmbH
- Country
- Netherlands (NL)
- ATC code
- N06DA02
- ATC class
- Donepezil
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id134874
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
355 interactions on record for donepezil.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Donepezil · interactions on record
355 records
- 8 severe
- 163 moderate
- 80 minor
- 102 info
Most severe, free to view
- OzanimodL04AA38severe
- SiponimodL04AA42severe
- OzanimodL04AE02severe
- SiponimodL04AE03severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06DA02
Donepezil, as other registers publish it.
- CanadaACH-DONEPEZILACCORD HEALTHCARE INC
- CanadaACH-DONEPEZILACCORD HEALTHCARE INC
- CanadaAG-DONEPEZILANGITA PHARMA INC.
- CanadaAG-DONEPEZILANGITA PHARMA INC.
- CzechiaALZILGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALZILGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALZILGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALZILGlenmark Pharmaceuticals s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0f80362-d401-4de4-8c14-2674542e53e5 GET /v1/drugs/e0f80362-d401-4de4-8c14-2674542e53e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134874_smpc.pdf",
"strength": null,
"atc_label": "Donepezil",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134874",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROLOSE (E 463)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"PROPYLEENGLYCOL (E 1520)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"ZETMEEL, GEPREGELATINEERD"
],
"substances": [
"DONEPEZIL",
"DONEPEZILHYDROCHLORIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134874.pdf",
"authorised_at": "2026/08/24",
"procedure_number": "AT/H/1500/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "134874",
"additional_monitoring": "N"
}See everything about donepezil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.